GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Other Operating Expense

Assertio Holdings (FRA:DPOA) Other Operating Expense : €24.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Other Operating Expense?

Assertio Holdings's Other Operating Expense for the three months ended in Mar. 2024 was €5.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €24.9 Mil.

Assertio Holdings's quarterly Other Operating Expense declined from Sep. 2023 (€9.5 Mil) to Dec. 2023 (€4.4 Mil) but then increased from Dec. 2023 (€4.4 Mil) to Mar. 2024 (€5.2 Mil).

Assertio Holdings's annual Other Operating Expense increased from Dec. 2021 (€24.9 Mil) to Dec. 2022 (€30.8 Mil) but then declined from Dec. 2022 (€30.8 Mil) to Dec. 2023 (€25.2 Mil).


Assertio Holdings Other Operating Expense Historical Data

The historical data trend for Assertio Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Other Operating Expense Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.60 20.37 24.88 30.78 25.24

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.87 5.80 9.54 4.38 5.18

Assertio Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €24.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Assertio Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Assertio Holdings (FRA:DPOA) Business Description

Traded in Other Exchanges
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines